Firefly Neuroscience, Inc. (AIFF) 10-Year Financial Performance & Capital Metrics

AIFF • • Industrial / General

TechnologyApplication SoftwareArtificial Intelligence & AnalyticsHealthcare AI

AboutFirefly Neuroscience, Inc., a medical technology and artificial intelligence company, provides neuroscientific solutions that improve outcomes for patients with mental illnesses and neurological disorders. The company offers Brain Network Analytics, a software that focuses on diagnostic and treatment for people suffering from mental illnesses and cognitive disorders, including depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder. It serves pharmaceutical companies and medical practitioners. Firefly Neuroscience, Inc. is based in Toronto, Canada.Show more

Revenue $108K -78.3%
EBITDA -$9M -252.7%
Net Income -$10M -301.8%
EPS (Diluted) -1.60 -384.8%
Gross Margin 37.96% -62.0%
EBITDA Margin -8437.96% -1526.2%
Operating Margin -8500% -1275.2%
Net Margin -9685.19% -1752.9%
ROE -
ROIC -
Debt/Equity -
Interest Coverage -133.04 +22.2%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Share count reduced 16.8% through buybacks

✗Weaknesses

✗Weak Piotroski F-Score: 3/9
✗Negative free cash flow
✗Weak momentum: RS Rating 5 (bottom 5%)
✗Trading more than 30% below 52-week high
✗Low asset turnover indicates capital-intensive operations

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y-

5Y-

3Y50%

TTM-60.21%

Profit (Net Income) CAGR

10Y-

5Y-

3Y-

TTM-208.05%

EPS CAGR

10Y-

5Y-

3Y-

TTM-185.84%

ROCE

10Y Avg-1401.48%

5Y Avg-1401.48%

3Y Avg-2823.85%

Latest-

Peer Comparison

Healthcare AI

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
AIFFFirefly Neuroscience, Inc.	14.03M	1.04	-0.65	-78.31%	-27.06%	-219.4%

Profit & Loss

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	13.9M	32K	0	498K	108K
Revenue Growth %	-	-1%	-1%	-	-0.78%
Cost of Goods Sold+	11.69M	0	0	0	67K
COGS % of Revenue	0.84%	-	-	-	0.62%
Gross Profit+	2.21M	32K	0	498K	41K
Gross Margin %	0.16%	1%	-	1%	0.38%
Gross Profit Growth %	-	-0.99%	-1%	-	-0.92%
Operating Expenses+	1.8M	4.69M	3.33M	3.58M	9.22M
OpEx % of Revenue	0.13%	146.44%	-	7.18%	85.38%
Selling, General & Admin	1.8M	1.68M	1.98M	2.83M	7.33M
SG&A % of Revenue	0.13%	52.53%	-	5.69%	67.91%
Research & Development	0	2.93M	1.27M	741K	1.95M
R&D % of Revenue	-	91.44%	-	1.49%	18.09%
Other Operating Expenses	0	79K	77K	0	-67K
Operating Income+	411.85K	-4.65M	-3.33M	-3.08M	-9.18M
Operating Margin %	0.03%	-145.44%	-	-6.18%	-85%
Operating Income Growth %	-	-12.3%	0.28%	0.08%	-1.98%
EBITDA+	423.91K	-4.22M	-3.31M	-2.58M	-9.11M
EBITDA Margin %	0.03%	-132.03%	-	-5.19%	-84.38%
EBITDA Growth %	-	-10.97%	0.22%	0.22%	-2.53%
D&A (Non-Cash Add-back)	12.06K	429K	14K	0	67K
EBIT	413.38K	-4.25M	-3.21M	-2.58M	-10.39M
Net Interest Income+	0	-135K	-574K	-18K	-69K
Interest Income	0	0	0	0	0
Interest Expense	0	135K	574K	18K	69K
Other Income/Expense	1.53K	273K	-460K	476K	-1.28M
Pretax Income+	413.38K	-4.38M	-3.79M	-2.6M	-10.46M
Pretax Margin %	0.03%	-136.91%	-	-5.22%	-96.83%
Income Tax+	0	0	0	1K	2K
Effective Tax Rate %	1%	1%	1%	1%	1%
Net Income+	413.38K	-4.38M	-3.79M	-2.6M	-10.46M
Net Margin %	0.03%	-136.91%	-	-5.23%	-96.85%
Net Income Growth %	-	-11.6%	0.14%	0.31%	-3.02%
Net Income (Continuing)	413.38K	-4.38M	-3.79M	-2.6M	-10.46M
Discontinued Operations	0	0	0	0	0
Minority Interest	0	0	0	0	0
EPS (Diluted)+	0.05	-0.56	-0.48	-0.33	-1.60
EPS Growth %	-	-11.67%	0.14%	0.31%	-3.85%
EPS (Basic)	0.05	-0.56	-0.48	-0.33	-1.60
Diluted Shares Outstanding	7.87M	7.87M	7.87M	7.87M	6.55M
Basic Shares Outstanding	7.87M	7.87M	7.87M	7.87M	6.55M
Dividend Payout Ratio	-	-	-	-	-

Balance Sheet

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	3.35M	703K	83K	2.25M	2.63M
Cash & Short-Term Investments	1.86M	653K	58K	2.14M	1.81M
Cash Only	1.86M	653K	58K	2.14M	1.81M
Short-Term Investments	0	0	0	0	0
Accounts Receivable	1.44M	41K	19K	84K	121K
Days Sales Outstanding	37.86	467.66	-	61.57	408.94
Inventory	0	0	0	0	0
Days Inventory Outstanding	-	-	-	-	-
Other Current Assets	27.63K	0	0	0	280K
Total Non-Current Assets+	419.61K	250K	52K	386K	1.97M
Property, Plant & Equipment	113.57K	188K	0	0	136K
Fixed Asset Turnover	122.42x	0.17x	-	-	0.79x
Goodwill	0	0	0	0	0
Intangible Assets	0	1K	0	386K	180K
Long-Term Investments	210.69K	0	0	0	0
Other Non-Current Assets	95.35K	61K	52K	0	1.66M
Total Assets+	3.77M	953K	135K	2.64M	4.6M
Asset Turnover	3.68x	0.03x	-	0.19x	0.02x
Asset Growth %	-	-0.75%	-0.86%	18.56%	0.74%
Total Current Liabilities+	1.8M	3.97M	2.25M	2.53M	4.98M
Accounts Payable	103.65K	500K	420K	630K	1.82M
Days Payables Outstanding	3.24	-	-	-	9.89K
Short-Term Debt	138.6K	1.79M	0	0	694K
Deferred Revenue (Current)	946.88K	459K	909K	0	13K
Other Current Liabilities	57.4K	0	0	0	827K
Current Ratio	1.86x	0.18x	0.04x	0.89x	0.53x
Quick Ratio	1.86x	0.18x	0.04x	0.89x	0.53x
Cash Conversion Cycle	-	-	-	-	-
Total Non-Current Liabilities+	356.99K	0	0	0	0
Long-Term Debt	356.99K	0	0	0	0
Capital Lease Obligations	0	0	0	0	0
Deferred Tax Liabilities	0	0	0	0	0
Other Non-Current Liabilities	0	0	0	0	0
Total Liabilities	2.16M	3.97M	2.25M	2.53M	4.98M
Total Debt+	495.6K	1.79M	0	0	694K
Net Debt	-1.36M	1.14M	-58K	-2.14M	-1.12M
Debt / Equity	0.31x	-	-	-	-
Debt / EBITDA	1.17x	-	-	-	-
Net Debt / EBITDA	-3.21x	-	-	-	-
Interest Coverage	-	-34.47x	-5.80x	-171.00x	-133.04x
Total Equity+	1.61M	-3.01M	-2.11M	109K	-375K
Equity Growth %	-	-2.87%	0.3%	1.05%	-4.44%
Book Value per Share	0.20	-0.38	-0.27	0.01	-0.06
Total Shareholders' Equity	1.61M	-3.01M	-2.11M	109K	-375K
Common Stock	129.04K	0	19K	0	0
Retained Earnings	-12.31M	-67.33M	-73.91M	-76.62M	-87.08M
Treasury Stock	-930.21K	0	0	0	0
Accumulated OCI	0	0	0	0	0
Minority Interest	0	0	0	0	0

Cash Flow

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	423.26K	-3.82M	-2.89M	-2.17M	-6.16M
Operating CF Margin %	0.03%	-119.38%	-	-4.36%	-56.99%
Operating CF Growth %	-	-10.03%	0.24%	0.25%	-1.83%
Net Income	413.38K	-4.38M	-3.79M	-2.6M	-10.46M
Depreciation & Amortization	12.06K	429K	14K	0	67K
Stock-Based Compensation	0	608K	60K	295K	2.72M
Deferred Taxes	0	0	0	0	0
Other Non-Cash Items	27.63K	-283K	432K	0	1.07M
Working Capital Changes	-29.8K	-193K	391K	136K	445K
Change in Receivables	-984.21K	26K	27K	-65K	-37K
Change in Inventory	0	0	0	0	0
Change in Payables	-112.58K	206K	-80K	35K	883K
Cash from Investing+	-64.55K	1.6M	262K	-386K	-477K
Capital Expenditures	-64.55K	0	0	-386K	-148K
CapEx % of Revenue	0%	-	-	0.78%	1.37%
Acquisitions	-	-	-	-	-
Investments	-	-	-	-	-
Other Investing	0	597K	262K	0	-329K
Cash from Financing+	460K	2.04M	2.04M	4.64M	6.3M
Debt Issued (Net)	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-
Dividends Paid	0	0	0	0	0
Share Repurchases	-	-	-	-	-
Other Financing	0	0	0	0	36K
Net Change in Cash	-	-	-	-	-
Free Cash Flow+	358.72K	-3.82M	-2.89M	-2.56M	-6.57M
FCF Margin %	0.03%	-119.38%	-	-5.14%	-60.83%
FCF Growth %	-	-11.65%	0.24%	0.12%	-1.57%
FCF per Share	0.05	-0.49	-0.37	-0.33	-1.00
FCF Conversion (FCF/Net Income)	1.02x	0.87x	0.76x	0.83x	0.59x
Interest Paid	0	0	0	0	11K
Taxes Paid	0	0	0	0	0

Key Ratios

Metric	2020	2021	2022	2023	2024
Return on Equity (ROE)	25.62%	-	-	-2388.07%	-
Gross Margin	15.89%	100%	-	100%	37.96%
Net Margin	2.97%	-13690.63%	-	-522.69%	-9685.19%
Debt / Equity	0.31x	-	-	-	-
Interest Coverage	-	-34.47x	-5.80x	-171.00x	-133.04x
FCF Conversion	1.02x	0.87x	0.76x	0.83x	0.59x
Revenue Growth	-	-99.77%	-100%	-	-78.31%

Frequently Asked Questions

Growth & Financials

Firefly Neuroscience, Inc. (AIFF) reported $0.8M in revenue for fiscal year 2024. This represents a 94% decrease from $13.9M in 2020.

Firefly Neuroscience, Inc. (AIFF) saw revenue decline by 78.3% over the past year.

Firefly Neuroscience, Inc. (AIFF) reported a net loss of $21.2M for fiscal year 2024.

Dividend & Returns

Firefly Neuroscience, Inc. (AIFF) had negative free cash flow of $7.8M in fiscal year 2024, likely due to heavy capital investments.

← Back to Screener